Nvidia's Earnings Will Assess the AI Surge
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 27 2025
0mins
Should l Buy INTC?
Source: Benzinga
Nvidia Earnings Outlook: Nvidia is set to report earnings soon, with analysts' whisper numbers indicating higher expectations than consensus. The stock has not shown strong upward movement despite recent market optimism.
Market Reactions and Rate Cuts: Following Fed Chair Powell's hints at a potential rate cut in September, the stock market reacted positively, but there remains uncertainty about the specifics of the cuts and their impact on inflation.
Chinese Stocks Performance: There is a notable influx of investment into Chinese stocks as investors believe China is gaining an advantage in trade negotiations with the U.S., leading to significant gains in major Chinese indices.
Investment Strategies and Protection Bands: Investors are advised to maintain long-term positions while considering protective measures such as cash reserves or short-term hedges, especially in light of current market volatility and inflation concerns.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy INTC?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on INTC
Wall Street analysts forecast INTC stock price to fall
29 Analyst Rating
5 Buy
19 Hold
5 Sell
Hold
Current: 44.060
Low
20.00
Averages
39.30
High
52.00
Current: 44.060
Low
20.00
Averages
39.30
High
52.00
About INTC
Intel Corporation is a global designer and manufacturer of semiconductor products. The Company operates through three segments: Intel Products, Intel Foundry, and All Other. Its Intel Products segment includes Client Computing Group (CCG), Data Center and AI (DCAI), Network and Edge (NEX). The CCG is bringing together the operating system, system architecture, hardware, and software application integration to enable PC experiences. DCAI delivers workload-optimized solutions to cloud service providers and enterprises, along with silicon devices for communications service providers, network and edge, and HPC customers. NEX helps networks and edge compute systems from fixed-function hardware to general-purpose compute, acceleration, and networking devices running cloud native software on programmable hardware. The Intel Foundry segment comprises technology development, manufacturing and foundry services. All Other segments include Altera, Mobileye, Other.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
AMD Shares Rise 7.26% Driven by AI Demand and Price Hikes
- Stock Price Surge: AMD shares rose 7.26% to close at $220.27, primarily driven by planned CPU price hikes and robust AI infrastructure demand, indicating enhanced pricing power in core markets.
- Volume Spike: The trading volume reached 47.2 million shares, approximately 31% above the three-month average of 36 million shares, reflecting strong investor interest in AMD's future prospects, particularly amid sustained demand for AI products.
- Positive Market Reaction: With expectations of rising CPU prices, investors are optimistic about AMD's AI accelerators and new partnerships, which could drive stronger earnings guidance in the upcoming reports.
- Investor Focus: Investors will closely monitor whether AMD can achieve margin expansion through higher pricing and sustained AI demand, and whether it can provide stronger guidance in future earnings, further solidifying its market position.
See More
AMD Shares Rise 7.26% on AI Demand and Price Hike Plans
- Stock Price Surge: AMD closed at $220.27 on Wednesday, up 7.26%, primarily driven by CPU price hike plans and robust AI infrastructure demand, reflecting market optimism about its future performance.
- Volume Spike: The company's trading volume reached 47.2 million shares, approximately 31% above its three-month average of 36 million shares, indicating a significant increase in investor interest in AMD.
- Enhanced Pricing Power: AMD's plans to raise CPU prices suggest stronger pricing power in core markets, while sustained demand for AI products and a large accelerator order reinforce its position in the data center market.
- Investor Focus on Future: As investors closely monitor upcoming earnings and guidance for AI infrastructure revenue, the rise in AMD's stock price may lead to margin expansion and stronger performance expectations.
See More
Corcept Therapeutics Receives FDA Approval for Lifyorli
- FDA Approval: Corcept Therapeutics' Lifyorli has received FDA approval for use in combination with nab-paclitaxel to treat platinum-resistant ovarian cancer, marking a significant advancement in the company's cancer treatment portfolio.
- Stock Surge: Following the FDA approval announcement, Corcept's shares soared nearly 20% in value on the same day, reflecting strong market confidence in the new drug's potential and boosting investor sentiment.
- Successful Clinical Trials: The approval was based on the positive outcomes from the Rosella trial involving 381 patients, demonstrating the drug's efficacy in treatment and further validating the company's unique focus on cortisol modulation.
- Future Growth Potential: CEO Joseph Belanoff emphasized that today's approval is just the first step, indicating that the company will continue to explore additional treatment options, with the potential for more FDA approvals in the future to drive long-term growth.
See More
Arm Holdings Launches Own CPUs, Stock Surges
- Revenue Surge Forecast: Arm Holdings projects total revenue to reach $25 billion by 2031, with $15 billion coming from its newly launched CPUs, indicating a strategic shift in response to the rapidly growing AI market.
- Market Share Ambitions: Arm aims to capture a 15% share in the CPU market, which is expected to quadruple to $100 billion, a move that not only boosts its growth prospects but also reshapes the competitive landscape of the semiconductor industry.
- Increased Competition Impact: While new entrants typically pose challenges, Arm's entry is likely to tighten supply, with CPU prices expected to rise by 10% to 15% this year, benefiting market leaders AMD and Intel as well.
- AI Infrastructure Partnerships: AMD's collaborations with OpenAI and Meta Platforms, primarily focused on GPUs, will be further enhanced by competition with Arm, positioning AMD for significant success in the data center CPU market in the coming years.
See More
Arm Enters Data Center CPU Market with Huge Revenue Projections
- Market Share Target: Arm aims to capture a 15% share of the data center CPU market, which is projected to grow fourfold to $100 billion, significantly enhancing the company's market position and revenue potential.
- Revenue Forecast: Arm anticipates total revenue reaching $25 billion by 2031, with $15 billion coming from its newly launched CPUs, marking a shift from its traditional IP licensing model to direct manufacturing, which could yield higher profit margins.
- Competitive Landscape Shift: As CPU demand surges, AMD and Intel are also raising prices, with increases expected between 10% and 15%, which will further drive revenue growth for Arm and its competitors, especially against the backdrop of rapid AI infrastructure development.
- Impact of Technical Partnerships: AMD's collaborations with OpenAI and Meta Platforms, while primarily focused on GPUs, could accelerate its success in the data center CPU market through competition with Arm, further solidifying its market leadership.
See More
Zelenskiy Expresses Ukraine's Desire for Long-Term Drone Agreements with Gulf Nations
Ukrainian Drone Deals: President Zelensky expresses Ukraine's intention to secure long-term drone agreements with various Gulf countries.
Focus on Defense: The emphasis on drone deals highlights Ukraine's strategy to enhance its defense capabilities amid ongoing conflicts.
See More
AMD Shares Rise 7.26% Driven by AI Demand and Price Hikes
- Stock Price Surge: AMD shares rose 7.26% to close at $220.27, primarily driven by planned CPU price hikes and robust AI infrastructure demand, indicating enhanced pricing power in core markets.
- Volume Spike: The trading volume reached 47.2 million shares, approximately 31% above the three-month average of 36 million shares, reflecting strong investor interest in AMD's future prospects, particularly amid sustained demand for AI products.
- Positive Market Reaction: With expectations of rising CPU prices, investors are optimistic about AMD's AI accelerators and new partnerships, which could drive stronger earnings guidance in the upcoming reports.
- Investor Focus: Investors will closely monitor whether AMD can achieve margin expansion through higher pricing and sustained AI demand, and whether it can provide stronger guidance in future earnings, further solidifying its market position.
See More
AMD Shares Rise 7.26% on AI Demand and Price Hike Plans
- Stock Price Surge: AMD closed at $220.27 on Wednesday, up 7.26%, primarily driven by CPU price hike plans and robust AI infrastructure demand, reflecting market optimism about its future performance.
- Volume Spike: The company's trading volume reached 47.2 million shares, approximately 31% above its three-month average of 36 million shares, indicating a significant increase in investor interest in AMD.
- Enhanced Pricing Power: AMD's plans to raise CPU prices suggest stronger pricing power in core markets, while sustained demand for AI products and a large accelerator order reinforce its position in the data center market.
- Investor Focus on Future: As investors closely monitor upcoming earnings and guidance for AI infrastructure revenue, the rise in AMD's stock price may lead to margin expansion and stronger performance expectations.
See More
Corcept Therapeutics Receives FDA Approval for Lifyorli
- FDA Approval: Corcept Therapeutics' Lifyorli has received FDA approval for use in combination with nab-paclitaxel to treat platinum-resistant ovarian cancer, marking a significant advancement in the company's cancer treatment portfolio.
- Stock Surge: Following the FDA approval announcement, Corcept's shares soared nearly 20% in value on the same day, reflecting strong market confidence in the new drug's potential and boosting investor sentiment.
- Successful Clinical Trials: The approval was based on the positive outcomes from the Rosella trial involving 381 patients, demonstrating the drug's efficacy in treatment and further validating the company's unique focus on cortisol modulation.
- Future Growth Potential: CEO Joseph Belanoff emphasized that today's approval is just the first step, indicating that the company will continue to explore additional treatment options, with the potential for more FDA approvals in the future to drive long-term growth.
See More
Arm Holdings Launches Own CPUs, Stock Surges
- Revenue Surge Forecast: Arm Holdings projects total revenue to reach $25 billion by 2031, with $15 billion coming from its newly launched CPUs, indicating a strategic shift in response to the rapidly growing AI market.
- Market Share Ambitions: Arm aims to capture a 15% share in the CPU market, which is expected to quadruple to $100 billion, a move that not only boosts its growth prospects but also reshapes the competitive landscape of the semiconductor industry.
- Increased Competition Impact: While new entrants typically pose challenges, Arm's entry is likely to tighten supply, with CPU prices expected to rise by 10% to 15% this year, benefiting market leaders AMD and Intel as well.
- AI Infrastructure Partnerships: AMD's collaborations with OpenAI and Meta Platforms, primarily focused on GPUs, will be further enhanced by competition with Arm, positioning AMD for significant success in the data center CPU market in the coming years.
See More
Arm Enters Data Center CPU Market with Huge Revenue Projections
- Market Share Target: Arm aims to capture a 15% share of the data center CPU market, which is projected to grow fourfold to $100 billion, significantly enhancing the company's market position and revenue potential.
- Revenue Forecast: Arm anticipates total revenue reaching $25 billion by 2031, with $15 billion coming from its newly launched CPUs, marking a shift from its traditional IP licensing model to direct manufacturing, which could yield higher profit margins.
- Competitive Landscape Shift: As CPU demand surges, AMD and Intel are also raising prices, with increases expected between 10% and 15%, which will further drive revenue growth for Arm and its competitors, especially against the backdrop of rapid AI infrastructure development.
- Impact of Technical Partnerships: AMD's collaborations with OpenAI and Meta Platforms, while primarily focused on GPUs, could accelerate its success in the data center CPU market through competition with Arm, further solidifying its market leadership.
See More
Zelenskiy Expresses Ukraine's Desire for Long-Term Drone Agreements with Gulf Nations
Ukrainian Drone Deals: President Zelensky expresses Ukraine's intention to secure long-term drone agreements with various Gulf countries.
Focus on Defense: The emphasis on drone deals highlights Ukraine's strategy to enhance its defense capabilities amid ongoing conflicts.
See More
